Table 3.
Stroke treatment and time course
| Pre-COVID-19 period group (n = 112) | COVID-19 period group (n = 83) | p value | |
|---|---|---|---|
| Stroke treatment, n (%) | |||
| Intravenous thrombolysis | 15 (17.2) | 16 (26.2) | 0.186 |
| Mechanical thrombectomy | 19 (21.8) | 10 (16.4) | 0.411 |
| Total patients treated (IVT or MT) | 30 (34.5) | 20 (32.8) | 0.830 |
| Time course | |||
| Median onset-to-door time, min (IQR) | 197 (91.25–645) | 304 (93–760) | 0.104 |
| Onset-to-door within 4.5 h, n (%) | 65 (58) | 36 (43.4) | 0.043 |
| Median door-to-CT time, min (IQR) | 26.5 (12–55.7) | 24 (16.5–44) | 0.592 |
| Median door-to-needle time, min (IQR) | 35 (21–60.5) | 37 (25.7–96) | 0.403 |
| Median door-to-groin time, min (IQR) | 95 (69–120) | 101.5 (70.2–113.5) | 0.910 |
Numbers are n (%), median (IQR) as appropriate. COVID-19, coronavirus disease 2019; IQR, interquartile range; n, number; IVT, intravenous thrombolysis; MT, mechanical thrombectomy; CT, computed tomography.